Prostate Specimen Reference Sets

Organ Protocol ID Reference set title Cases Controls Total participants Participant groups Specimen type Number of specimens Volume range (mL) Specimens at NCI-F? Discovery set? Follow-up data? Pathology Image files avail? Incident cancer?
Prostate

274

Prostate cancer (from PCA3)

341 559 900 ⁠⁠⁠⁠⁠ Serum 16,778 0.075–0.5
⁠⁠⁠

⁠⁠

⁠⁠

⁠⁠⁠ ⁠⁠⁠ ⁠⁠ ⁠⁠⁠ Buffy coat 864 0.05–0.5
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ Whole urine 771 1.2–5.0
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ EDTA plasma 13,137 0.1
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ Sediment/RNALater 738 0.035–1.5
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ Sediment/PBS 486 0.01–0.4
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ Supernatant 1,493 2.5–50
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ PAXGene 1,716 "tubes"
⁠⁠

⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ ⁠⁠⁠ ⁠⁠
Prostate

120

PROS-REF
(Discovery)

373 290 663 ⁠⁠ Serum 23,090 0.1–0.5 ⁠✓ ⁠✓
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ EDTA plasma 8,805 0.1–0.5
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ Citrate plasma 7,435 0.1–0.5
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ EDTA cellular fraction 4,074 0.1–0.5
⁠⁠

⁠⁠ ⁠⁠ ⁠⁠ Citrate cellular fraction 2,216 0.1–0.5
Prostate

382

URS (Prostate)

196 101 297 Cases and controls are defined by the overall Gleason score determined from prostatectomy. Controls had a score of 6. Cases had a score greater than 6. Buffy coat 295 0.5 ⁠ Yes (blood & urine) No (FFPE Biopsy & Prostatectomy Tissue distributed ⁠✓ ⁠✓

DNA 190 0.05

EDTA plasma 2860 0.2

⁠⁠

FFPE biopsy tissue 815

FFPE prostatectomy tissue 280

Raw urine 263 1.0

Sediment/PBS 86 0.05

Sediment/RNAlater 126 0.25

Serum 5158 0.1–0.25

Tissue slide 3177

Urine sediment 142 0.05

Urine supernatant 868 0.5–5.0

Whole blood 296 2.0

Whole urine 996 5.0